Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Cardiology
Volume 2014, Article ID 821812, 4 pages
http://dx.doi.org/10.1155/2014/821812
Case Report

A Case of Kawasaki Disease with Coronary Aneurysm Responding to the 4th IVIG Treatment

Department of Pediatrics, Eulji University Hospital, Eulji University School of Medicine, 1306, Dunsan-dong, Seo-gu, Daejeon 302-799, Republic of Korea

Received 30 December 2013; Revised 2 July 2014; Accepted 17 July 2014; Published 5 August 2014

Academic Editor: Monvadi Barbara Srichai

Copyright © 2014 Ju Young Kim and Hyun Jung Kim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. W. Newburger, M. Takahashi, A. S. Beiser et al., “A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome,” The New England Journal of Medicine, vol. 324, no. 23, pp. 1633–1639, 1991. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Nakamura, M. Yashiro, R. Uehara et al., “Case-control study of giant coronary aneurysms due to Kawasaki disease,” Pediatrics International, vol. 45, no. 4, pp. 410–413, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. J. W. Newburger, M. Takahashi, M. A. Gerber et al., “Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association,” Circulation, vol. 110, no. 17, pp. 2747–2771, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Egami, H. Muta, M. Ishii et al., “Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease,” Journal of Pediatrics, vol. 149, no. 2, pp. 237–240, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Hashino, M. Ishii, M. Iemura, T. Akagi, and H. Kato, “Re-treatment for immune globulin-resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy,” Pediatrics International, vol. 43, no. 3, pp. 211–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. J. C. Burns, B. M. Best, A. Mejias et al., “Infliximab treatment of intravenous immunoglobulin-resistant Kawasaki disease,” Journal of Pediatrics, vol. 153, no. 6, pp. 833–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. B. F. Son, K. Gauvreau, L. Ma et al., “Treatment of Kawasaki disease: analysis of 27 US Pediatric Hospitals from 2001 to 2006,” Pediatrics, vol. 124, no. 1, pp. 1–8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Ramesh and S. A. Schwartz, “Therapeutic uses of intravenous immunoglobulin in children.,” Pediatrics in Review, vol. 16, no. 11, pp. 403–410, 1995. View at Google Scholar · View at Scopus
  9. V. Gill, C. Doig, D. Knight, E. Love, and P. Kubes, “Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin,” Circulation, vol. 112, no. 13, pp. 2031–2039, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Ogata, Y. Bando, S. Kimura et al., “The strategy of immune globulin resistant Kawasaki disease: a comparative study of additional immune globulin and steroid pulse therapy,” Journal of Cardiology, vol. 53, no. 1, pp. 15–19, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Teraguchi, H. Ogino, K. Yoshimura et al., “Steroid pulse therapy for children with intravenous immunoglobulin therapy-resistant Kawasaki disease: a prospective study,” Pediatric Cardiology, vol. 34, no. 4, pp. 959–963, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Matsubara, S. Furukawa, and K. Yabuta, “Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions,” Clinical Immunology and Immunopathology, vol. 56, no. 1, pp. 29–36, 1990. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Mori, T. Imagawa, R. Hara et al., “Efficacy and limitation of infliximab treatment for children with Kawasaki disease intractable to intravenous immunoglobulin therapy: report of an open-label case series,” Journal of Rheumatology, vol. 39, no. 4, pp. 864–867, 2012. View at Publisher · View at Google Scholar · View at Scopus